BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thommi G, Shehan CJ, Mcleay MT. Fibrinolytics in parapneumonic effusions/empyemas. Chest 2014;146:e103-4. [PMID: 25180732 DOI: 10.1378/chest.14-0706] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Cheong XK, Ban AY, Ng BH, Nik Abeed NN, Nik Ismail NA, Nik Fuad NF, Syed Zakaria SZ, Ghan SL, Abdul Hamid MF. Modified regimen intrapleural alteplase with pulmozyme in pleural infection management: a tertiary teaching hospital experience. BMC Pulm Med 2022;22:199. [PMID: 35581627 DOI: 10.1186/s12890-022-01995-z] [Reference Citation Analysis]
2 Cheong XK, Yu-Lin Ban A, Abdul Hamid MF. Short-course intrapleural alteplase and DNase in complex effusion with bleeding risk. Respirol Case Rep 2020;8:e00648. [PMID: 32864139 DOI: 10.1002/rcr2.648] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Vun SV, Lance DG. Life-threatening pleural hemorrhage following intrapleural enzyme therapy and successful treatment with fibrin-thrombin sealant pleurodesis: a case report. J Med Case Rep 2015;9:287. [PMID: 26683839 DOI: 10.1186/s13256-015-0775-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Karandashova S, Florova G, Idell S, Komissarov AA. From Bedside to the Bench—A Call for Novel Approaches to Prognostic Evaluation and Treatment of Empyema. Front Pharmacol 2022;12:806393. [DOI: 10.3389/fphar.2021.806393] [Reference Citation Analysis]
5 Komissarov AA, Florova G, Azghani AO, Buchanan A, Bradley WM, Schaefer C, Koenig K, Idell S. The time course of resolution of adhesions during fibrinolytic therapy in tetracycline-induced pleural injury in rabbits. Am J Physiol Lung Cell Mol Physiol 2015;309:L562-72. [PMID: 26163512 DOI: 10.1152/ajplung.00136.2015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
6 Florova G, Girard RA, Azghani AO, Sarva K, Buchanan A, Karandashova S, DeVera CJ, Morris D, Chamiso M, Koenig K, Cines DB, Idell S, Komissarov AA. Precision targeting of the plasminogen activator inhibitor-1 mechanism increases efficacy of fibrinolytic therapy in empyema. Physiol Rep 2021;9:e14861. [PMID: 33991465 DOI: 10.14814/phy2.14861] [Reference Citation Analysis]